Merz Pharmaceuticals, LLC
Merz Pharmaceuticals, LLC, a prominent player in the global healthcare landscape, is headquartered in the United States. Founded in 1908, the company has established itself as a leader in the pharmaceutical and aesthetics industries, focusing on innovative solutions for neurology, dermatology, and aesthetic medicine. With a strong presence in North America and Europe, Merz Pharmaceuticals is renowned for its core products, including the well-regarded Xeomin® and Belotero® lines, which offer unique benefits in the realm of injectables. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in patient care. Merz Pharmaceuticals continues to excel in delivering high-quality, effective treatments, solidifying its market position through a dedication to innovation and excellence in the healthcare sector.
DitchCarbon Score
How does Merz Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merz Pharmaceuticals, LLC's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merz Pharmaceuticals, LLC's reported carbon emissions
Merz Pharmaceuticals, LLC, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing sustainability practices. As such, Merz Pharmaceuticals may be expected to align with industry standards and pursue climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merz Pharmaceuticals, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
